The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin
Glycemic variability (GV) is emerging as an exciting therapeutic target for diabetes mellitus (DM) with recent evidences showing association of GV with hypoglycemia risk as well as chronic complications.(1,2) Twice daily human premixed insulin is commonly used in developing countries and Asia fo...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrine Society
2020
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/31687/1/JES%20Vildagliptin%20GV.pdf http://ir.unimas.my/id/eprint/31687/ https://academic.oup.com/jes/article/4/Supplement_1/MON-653/5833510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|